GICRE:NSEGeneral Insurance Corporation of India Analysis
Data as of 2026-03-16 - not real-time
₹360.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
The stock is trading at 360 INR, notably below its 20‑day (≈377), 50‑day (≈375) and 200‑day (≈380) simple moving averages, signaling short‑term weakness. RSI sits at 37, flirting with oversold territory, while the MACD line remains negative with a bearish histogram, and volume has been slipping, suggesting limited buying pressure. Despite a 30‑day volatility of nearly 24%, the beta is very low (≈0.16), indicating the share moves less than the broader market.
Fundamentally, GICRE appears deeply discounted: a trailing P/E of 6.6 versus an industry average of 16.3, and a P/B of 0.63. Revenue is expanding at 11.6% YoY, profit margins hover around 18%, and the balance sheet is pristine with zero debt and ample cash. The dividend yield of 2.78% is supported by a modest 18% payout ratio, underscoring sustainability.
Overall, the valuation gap and solid fundamentals point to upside potential toward analyst target prices near 480 INR, yet technical pressures may keep the stock constrained in the near term. Investors should weigh the attractive value and dividend attributes against short‑term bearish signals and elevated volatility.
Fundamentally, GICRE appears deeply discounted: a trailing P/E of 6.6 versus an industry average of 16.3, and a P/B of 0.63. Revenue is expanding at 11.6% YoY, profit margins hover around 18%, and the balance sheet is pristine with zero debt and ample cash. The dividend yield of 2.78% is supported by a modest 18% payout ratio, underscoring sustainability.
Overall, the valuation gap and solid fundamentals point to upside potential toward analyst target prices near 480 INR, yet technical pressures may keep the stock constrained in the near term. Investors should weigh the attractive value and dividend attributes against short‑term bearish signals and elevated volatility.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price below short‑term moving averages
- bearish MACD histogram
- RSI approaching oversold levels
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- significant valuation discount (P/E 6.6 vs industry 16.3)
- solid revenue growth of 11.6% YoY
- attractive dividend yield of 2.78% with low payout
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- zero debt and strong cash position
- stable earnings and sustainable dividend
- low beta indicating defensive profile
Key Metrics & Analysis
Financial Health
Revenue Growth11.60%
Profit Margin18.32%
P/E Ratio6.6
ROE10.14%
ROA3.31%
P/B Ratio0.6
Industry P/E16.4
Technical Analysis
TrendNeutral
RSI37.4
Support₹350.25
Resistance₹396.75
MA 20₹377.27
MA 50₹375.46
MA 200₹379.58
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88
Valuation
Target Price₹476.00
Upside/Downside32.22%
GradeUndervalued
TypeBlend
Dividend Yield2.78%
Risk Assessment
Beta0.16
Volatility23.86%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.